News

Crucell said that the termination right was triggered by the acquisition of Shantha by sanofi pasteur in July 2009. Whereas, Sanofi pasteur would have to return the commercial

FDAS will use x-docs to store, manage and control vital records, ensure regulatory compliance and for laboratory efficiency to improve customer offering. FDAS needs eDMS to ensure that

The study results, published in The New England Journal of Medicine (NEJM Vol. 362 No. 25), also demonstrated cost savings in use of the fractional-dose intradermal injection as

The multiplex testing applications include tests for infectious diseases, cancer, companion diagnostics, autoimmune disease, genetic screening, and pharmacogenomics. The Applied BioCode’s BMB integrate the semiconductor’s photolithographic technology with

As per the terms of the agreement, AIM is expected to provide Health Evaluations; Immunizations; Ergonomic Education, Assessments and Programs; Health Education, Promotion and Training; and Workplace Investigations.

The successful inspection comes following Axxess Pharma’s most recent letter of intent (LOI) to acquire a Canada-based pharmaceutical manufacturer. Axxess Pharma’s facility is roughly 22,000sqft and manufactures pharmaceuticals,

Nymox said that compared to baseline, symptoms of urgency to urinate reduced by 52% at 90 days after a single treatment with NX-1207, and the improvement was positive

XP13512 is a patented new chemical entity discovered by XenoPort. GSK and XenoPort said that the failure of the study may be a consequence of the unexpectedly high

invivodata’s ePRO solutions, DiaryPRO and SitePRO, which are used for field-based data collection and for in-clinic based data collection are expected to provide complementary functionality to Total Clinical